Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing

Blood

Volumn 127, Issue 4, 2016, Pages 487-495

  Domingues, Marco M ^a,b   Macrae, Fraser L ^a   Duval, Cédric ^a   McPherson, Helen R ^a   Bridge, Katherine I ^a   Ajjan, Ramzi A ^a   Ridger, Victoria C ^c   Connell, Simon D ^b   Philippou, Helen ^a   Ariëns, Robert A S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; FIBRINOGEN GAMMA'; THROMBIN; UNCLASSIFIED DRUG; FIBRINOGEN VARIANT;

ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD; BLOOD CLOT; CHEMICAL STRUCTURE; ELECTRON MICROSCOPY; HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RIGIDITY; TRANSMISSION ELECTRON MICROSCOPY; TURBIDIMETRY; VISCOELASTICITY; BLOOD CLOTTING; BLOOD VISCOSITY; METABOLISM; PHOTOMETRY; THROMBOSIS; ULTRASTRUCTURE;

BLOOD COAGULATION; BLOOD VISCOSITY; FIBRINOGENS, ABNORMAL; HUMANS; MICROSCOPY, ATOMIC FORCE; NEPHELOMETRY AND TURBIDIMETRY; THROMBIN; THROMBOSIS;

EID: 84958073634     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-652214     Document Type: Article

References (56)

1. Lord ST. Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol. 2011;31(3):494-499.
2. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev. 2007;21(3):131-142.
3. Brown JH, Volkmann N, Jun. G, Henschen-Edman AH, Cohen C. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA. 2000;97(1):85-90.
4. Doolittle RF, Yang Z, Mochalkin I. Crystal structure studies on fibrinogen and fibrin. Ann N Y Acad Sci. 2001;936:31-43.
5. Yang Z, Kollman JM, Pandi L, Doolittle RF. Crystal structure of native chicken fibrinogen at 2.7 A resolution. Biochemistry. 2001;40(42):12515-12523.
6. Chung DW, Davie EW. gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry. 1984;23(18):4232-4236.
7. Francis CW, Marder VJ. Heterogeneity of normal human fibrinogen due to two high molecular weight variant gamma chains. Ann N Y Acad Sci. 1983;408:118-120.
8. Wolfenstein-Todel C, Mosesson MW. Carboxyterminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry. 1981;20(21):6146-6149.
9. Chan HH, Leslie BA, Stafford AR, et al. By increasing the affinity of heparin for fibrin, Zn (21) promotes the formation of a ternary heparinthrombinfibrin complex that protects thrombin from inhibition by antithrombin. Biochemistry. 2012;51(40):7964-7973.
10. de Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost. 2002;88(2):253-258.
11. Cooper AV, Standeven KF, Ariëns RA. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood. 2003;102(2):535-540.
12. Cheung EY, Uitte de Willige S, Vos HL, et al. Fibrinogen gamma' in ischemic stroke: a casecontrol study. Stroke. 2008;39(3):1033-1035.
13. Lovely RS, Falls LA, Al-Mondhiry HA, et al. Association of gammaA/gamma' fibrinogen levels and coronary artery disease. Thromb Haemost. 2002;88(1):26-31.
14. Mannila MN, Lovely RS, Kazmierczak SC, et al. Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost. 2007;5(4):766-773.
15. Mosesson MW, Hernandez I, Raife TJ, et al. Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost. 2007;5(1):62-69.
16. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood. 2005;106(13):4176-4183.
17. Veklich YI, Gorkun OV, Medved LV, Nieuwenhuizen W, Weisel JW. Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. J Biol Chem. 1993;268(18):13577-13585.
18. Litvinov RI, Yakovlev S, Tsurupa G, Gorkun OV, Medved L, Weisel JW. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry. 2007;46(31):9133-9142.
19. Medved L, Weisel JW; Fibrinogen and Factor XIII Subcommittee of Scientific Standardization Committee of International Society on Thrombosis and Haemostasis. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost. 2009;7(2):355-359.
20. Nair CH, Shah GA, Dhall DP. Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development. Thromb Res. 1986;42(6):809-816.
21. Glover CJ, McIntire LV, Brown CH III, Natelson EA. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition. J Lab Clin Med. 1975;86(4):644-656.
22. Duval C, Allan P, Connell SD, Ridger VC, Philippou H, Ariëns RA. Roles of fibrin a- and g-chain specific cross-linking by FXIIIa in fibrin structure and function. Thromb Haemost. 2014;111(5):842-850.
23. Hethershaw EL, Cilia La Corte AL, Duval C, et al. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. J Thromb Haemost. 2014;12(2):197-205.
24. Kurniawan NA, Grimbergen J, Koopman J, Koenderink GH. Factor XIII stiffens fibrin clots by causing fiber compaction. J Thromb Haemost. 2014;12(10):1687-1696.
25. Carr ME Jr, Gabriel DA, McDonagh J. Influence of Ca21 on the structure of reptilase-derived and thrombin-derived fibrin gels. Biochem J. 1986;239(3):513-516.
26. Blombäck B, Carlsson K, Fatah K, Hessel B, Procyk R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res. 1994;75(5):521-538.
27. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997(1-2):96-110.
28. Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood. 2003;101(8):3008-3013.
29. Undas A, Ariëns RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31(12):e88-e99.
30. Wolberg AS. Determinants of fibrin formation, structure, and function. Curr Opin Hematol. 2012;19(5):349-356.
31. Gersh KC, Nagaswami C, Weisel JW, Lord ST. The presence of gamma' chain impairs fibrin polymerization. Thromb Res. 2009;124(3):356-363.
32. Siebenlist KR, Mosesson MW, Hernandez I, et al. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood. 2005;106(8):2730-2736.
33. Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor-induced blood coagulation. Blood. 2002;100(1):148-152.
34. Allan P, Uitte de Willige S, Abou-Saleh RH, Connell SD, Ari ëns RA. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness. J Thromb Haemost. 2012;10(6):1072-1080.
35. Abou-Saleh RH, Connell SD, Harrand R, et al. Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbetachain residues is due to the formation of abnormal oligomers. Biophys J. 2009;96(6):2415-2427.
36. Evans RM, Tassieri M, Auhl D, Waigh TA. Direct conversion of rheological compliance measurements into storage and loss moduli. Phys Rev E Stat Nonlin Soft Matter Phys. 2009;80(1 Pt 1):012501.
37. Blinc A, Magdic J, Fric J, Musevic I. Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis. Fibrinolysis Proteolysis. 2000;14(5):288-299.
38. Pieters M, Kotze RC, Jerling JC, Kruger A, Ariëns RA. Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans. Blood. 2013;121(16):3254-3260.
39. Lovely RS, Boshkov LK, Marzec UM, Hanson SR, Farrell DH. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway. Br J Haematol. 2007;139(3):494-503.
40. Omarova F, Uitte De Willige S, Ariëns RA, Rosing J, Bertina RM, Castoldi E. Inhibition of thrombinmediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'. J Thromb Haemost. 2013;11(9):1669-1678.
41. Collet JP, Moen JL, Veklich YI, et al. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood. 2005;106(12):3824-3830.
42. Gorkun OV, Veklich YI, Weisel JW, Lord ST. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood. 1997;89(12):4407-4414.
43. Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of fibrin clot rheology. Biophys J. 1999;77(5):2813-2826.
44. Veklich Y, Francis CW, White J, Weisel JW. Structural studies of fibrinolysis by electron microscopy. Blood. 1998;92(12):4721-4729.
45. Lim BB, Lee EH, Sotomayor M, Schulten K. Molecular basis of fibrin clot elasticity. Structure. 2008;16(3):449-459.
46. Carr ME Jr, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules. 1978;11(1):46-50.
47. Yeromonahos C, Polack B, Caton F. Nanostructure of the fibrin clot. Biophys J. 2010;99(7):2018-2027.
48. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost. 2000;83(4):589-591.
49. Mann KG. Thrombin formation. Chest. 2003;124(3 Suppl):4S-10S.
50. Liu W, Jawerth LM, Sparks EA, et al. Fibrin fibers have extraordinary extensibility and elasticity. Science. 2006;313(5787):634.
51. Shah JV, Janmey PA. Strain hardening of fibrin gels and plasma clots. Rheol Acta. 1997;36(3):262-268.
52. Guthold M, Liu W, Sparks EA, et al. A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem Biophys. 2007;49(3):165-181.
53. Brown AE, Litvinov RI, Discher DE, Purohit PK, Weisel JW. Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water. Science. 2009;325(5941):741-744.
54. Piechocka IK, Bacabac RG, Potters M, Mackintosh FC, Koenderink GH. Structural hierarchy governs fibrin gel mechanics. Biophys J. 2010;98(10):2281-2289.
55. Houser JR, Hudson NE, Ping L, et al. Evidence that aC region is origin of low modulus, high extensibility, and strain stiffening in fibrin fibers. Biophys J. 2010;99(9):3038-3047.
56. Bucay I, O'Brien ET III, Wulfe SD, et al. Physical determinants of fibrinolysis in single fibrin fibers. PLoS One. 2015;10(2):e0116350.